HomeCompareVUSXX vs MRK

VUSXX vs MRK: Dividend Comparison 2026

VUSXX yields 200.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VUSXX wins by $119.31M in total portfolio value
10 years
VUSXX
VUSXX
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full VUSXX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VUSXX vs MRK

📍 VUSXX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVUSXXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VUSXX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VUSXX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VUSXX
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, VUSXX beats the other by $51,141,353.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VUSXX + MRK for your $10,000?

VUSXX: 50%MRK: 50%
100% MRK50/50100% VUSXX
Portfolio after 10yr
$59.71M
Annual income
$30,092,947.21/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VUSXX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VUSXX buys
0
MRK buys
0
No recent congressional trades found for VUSXX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVUSXXMRK
Forward yield200.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$119.36M$56.8K
Annual income after 10y$60,176,096.29$9,798.13
Total dividends collected$112.49M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VUSXX vs MRK ($10,000, DRIP)

YearVUSXX PortfolioVUSXX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$30,700$20,000.00$11,206$366.19+$19.5KVUSXX
2$90,232$57,383.18$12,650$502.35+$77.6KVUSXX
3$254,173$157,624.56$14,407$694.19+$239.8KVUSXX
4$686,927$414,961.74$16,585$967.82+$670.3KVUSXX
5$1,783,118$1,048,106.39$19,342$1,363.89+$1.76MVUSXX
6$4,450,613$2,542,677.12$22,913$1,947.19+$4.43MVUSXX
7$10,693,420$5,931,263.38$27,662$2,823.89+$10.67MVUSXX
8$24,760,608$13,318,648.86$34,159$4,173.35+$24.73MVUSXX
9$55,315,649$28,821,798.66$43,337$6,308.80+$55.27MVUSXX
10$119,363,841$60,176,096.29$56,776$9,798.13+$119.31MVUSXX

VUSXX vs MRK: Complete Analysis 2026

VUSXXStock

Vanguard Treasury Money Market Fund, which invests primarily in U.S. Treasury securities, seeks to provide current income and preserve shareholders’ principal investment by maintaining a share price of $1. This fund at a minimum invests 80% of the assets in debt issued directly by the government in the form of Treasury bills and in repurchase agreements fully collateralized by U.S. Treasury securities. As a government money market fund, this fund is required to invest at least 99.5% of its total assets in cash, U.S. government securities, and/or repurchase agreements that are collateralized solely by U.S. government securities or cash (collectively, government securities). As such it is considered one of the most conservative investment options offered by Vanguard. Although the fund invests primarily in short-term U.S. Treasury bills, the amount of income that a shareholder may receive will be largely dependent on the current interest rate environment. Investors who have short-term savings goals and want the added security of investing in a fund in which the majority of the underlying securities are backed by the full faith and credit of the U.S. government may wish to consider this option.Important Note:&nbsp;Income generated from investments in repurchase agreements with the federal reserve are generally subject to state and local income taxes.

Full VUSXX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VUSXX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VUSXX vs SCHDVUSXX vs JEPIVUSXX vs OVUSXX vs KOVUSXX vs MAINVUSXX vs JNJVUSXX vs ABBVVUSXX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.